Prof. Dr. med. Ricardo Grieshaber Bouyer

Professur für Klinische Systemimmunologie

BCMA CAR T cells in a patient with relapsing idiopathic inflammatory myositis after initial and repeat therapy with CD19 CAR T cells (2025) Müller F, Wirsching A, Hagen M, Völkl S, Tur C, Raimondo MG, Taubmann J, et al. Journal article CytoNormPy Enables a Fast and Scalable Removal of Batch Effects in Cytometry Datasets (2025) Exner T, Hackert N, Leomazzi L, Van Gassen S, Saeys Y, Lorenz HM, Grieshaber-Bouyer R Journal article Treatment of CNS systemic lupus erythematosus with CD19 CAR T cells (2024) Hagen M, Müller F, Wirsching A, Kharboutli S, Spörl S, Aigner M, Völkl S, et al. Journal article CD19-CAR T-cell therapy induces deep tissue depletion of B cells (2024) Tur C, Eckstein M, Velden J, Rauber S, Bergmann C, Auth J, Bucci L, et al. Journal article Bispecific T cell engager therapy for refractory rheumatoid arthritis (2024) Bucci L, Hagen M, Rothe T, Raimondo MG, Fagni F, Tur C, Wirsching A, et al. Journal article Selective CAR T cell–mediated B cell depletion suppresses IFN signature in SLE (2024) Wilhelm A, Chambers D, Müller F, Bozec A, Grieshaber Bouyer R, Winkler T, Mougiakakos D, et al. Journal article BCMA-Targeted T-Cell-Engager Therapy for Autoimmune Disease. (2024) Hagen M, Bucci L, Böltz S, Nöthling DM, Rothe T, Anoshkin K, Raimondo MG, et al. Journal article, Letter CD19-targeting CAR T-cell therapy in patients with diffuse systemic sclerosis: a case series (2024) Auth J, Müller F, Völkl S, Bayerl N, Distler JH, Tur C, Raimondo MG, et al. Journal article CAR-T-Zell-Therapie in der Rheumatologie – Was wissen wir bisher? (2024) Hagen M, Wirsching A, Bohr D, Taubmann J, Müller F, Mackensen A, Grieshaber Bouyer R, Schett G Journal article CD19 Chimeric Antigen Receptor T Cell Treatment: Unraveling the Role of B Cells in Systemic Lupus Erythematosus. (2024) Taubmann J, Müller F, Mutlu MY, Völkl S, Aigner M, Bozec A, Mackensen A, et al. Journal article, Review article